Minneapolis, Minn.-based medical technology provider Medtronic and India-based Apollo Hospitals Enterprise Ltd. are collaborating to introduce kidney dialysis to India. Apollo Hospitals chairman Dr. Prathap C. Reddy, said, “Our partnership with Medtronic will help in fulfilling our vision of delivering better clinical outcomes through bench-to-bedside innovation.” Medtronic has developed a hemodialysis method that filters toxins from the blood of those with kidneys too damaged to function properly. The companies are designing a low-cost, portable system to be introduced into the developing world by 2016 that doesn’t depend heavily on infrastructure. Medtronic will invest over $25 million to design, develop and manufacture key components of the system in India for the first time. “In the case of hemodialysis, both the cost and lack of mobility of current systems have made broader access to dialysis treatment difficult and expensive,” said Medtronic CEO Omar Ishrak. “Our goal is to build a unique, internally developed system that will be portable, will lower costs and will be more efficient in its use of water and other critical features than existing dialysis systems.” About 10 percent of adults in India (nearly 75 million) suffer from chronic kidney disease. It is estimated that nearly 200,000 new end stage renal disease patients require dialysis or kidney transplants every year.